Lantheus

Investors Rally for Justice: Securities Class Action Filed Against Lantheus Holdings Amid Misrepresentation Claims

by

NEW YORK — A securities class action lawsuit has been launched against Lantheus Holdings, Inc., a company listed on NASDAQ under the symbol LNTH. The complaint, filed by a shareholder, seeks to represent investors who acquired Lantheus securities between February 26 and August 5, 2025. The lawsuit alleges that the defendants made false statements regarding the competitive standing of Lantheus’s key product, Pylarify, a radiopharmaceutical used in oncology. Investors who believe they have been affected by these misrepresentations are urged to consider their legal options. Shareholders who bought Lantheus securities during the specified period and … Read more

Investors Rally as Class Action Suit Against Lantheus Holdings Unfolds: Key Dates and Allegations Revealed

by

RADNOR, Pa. – A class action lawsuit has been filed against Lantheus Holdings, Inc., aimed at investors who acquired securities of the company between February 26 and August 5, 2025. The law firm Kessler Topaz Meltzer & Check, LLP announced that those who wish to act as lead plaintiffs in the case have until November 10, 2025, to file their applications. The lawsuit alleges that Lantheus made false and misleading representations regarding the competitive standing of its product, PYLARIFY. Specifically, it claims the company failed to properly evaluate pricing and competition, leading to potential risks … Read more